Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
Advance Auto Parts: Goldman Sachs adjusts price target to $247 from $261, maintains buy rating.
Advanced Micro Devices: Piper Sandler raised its recommendation to overweight from neutral. PT jumps 49% to $140.
Aspen Technology: Piper Sandler adjusts price target to $159 from $170, maintains neutral rating.
Camden Property: Goldman Sachs downgrades to neutral from buy. PT up 9.6% to $158.
CarMax: Evercore ISI adjusts price target to $105 from $85, maintains in-line rating.
Equity Residential: Mizuho Securities raised its recommendation to buy from neutral. PT up 13% to $84.
Essex Property: Goldman Sachs raised its recommendation on Essex Property Trust Inc. to buy from sell.
Gilead Sciences: Piper Sandler adjusts price target to $69 from $73, maintains neutral rating.
Global-E Online: KeyBanc adjusts price target to $25 from $45, reiterates overweight rating.
J.B. Hunt: Benchmark Company initiated coverage with a recommendation of buy. PT up 24% to $215.
Monday.com: Piper Sandler adjusts price target to $200 from $250, reiterates overweight rating.
Palo Alto Networks: KeyBanc adjusts price target to $610 from $729, reiterates overweight rating.
PBF Energy: J.P. Morgan upgrades to neutral from underweight. PT up 9.5% to $34.
Shake Shack: Raymond James upgrades to market perform from underperform.
Teva Pharmaceutical Industries: BofA Securities upgrades teva pharmaceutical industries to neutral from underperform; price target is $9.
Unilever: Moves from hold to sell targeting GBp 3400.
Upwork: Stifel downgrades to hold from buy, adjusts price target to $20 from $30.